These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 9124985

  • 1. [Results of a "round table" on cefpirome (Keiten)].
    Navashin SM, Navashin PS.
    Antibiot Khimioter; 1996; 41(12):40-2. PubMed ID: 9124985
    [No Abstract] [Full Text] [Related]

  • 2. Cefpirome: epidemiological survey in intensive care units and hematological units in The Netherlands. The Dutch Study Group.
    Hoogkamp-Korstanje JA, Verduyn Lunel F, Meis JF.
    Diagn Microbiol Infect Dis; 1998 Jul; 31(3):489-91. PubMed ID: 9635243
    [No Abstract] [Full Text] [Related]

  • 3. [Cefepime--a fourth generation cephalosporin antibiotic].
    Iakovlev SV.
    Antibiot Khimioter; 1999 Jul; 44(7):32-7. PubMed ID: 10494381
    [No Abstract] [Full Text] [Related]

  • 4. [Effectiveness of cefpirome in the treatment of complicated infections of the upper and lower urinary tracts].
    Derevianko II, Kotliarova GA, Kondrat'eva EM, Khodyreva LA, Siniukhin VN.
    Antibiot Khimioter; 1996 Jul; 41(12):30-3. PubMed ID: 9124983
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ceftobiprole: breaking therapeutic dogmas of the beta-lactam class.
    Deresinski SC.
    Diagn Microbiol Infect Dis; 2008 May; 61(1):82-5. PubMed ID: 18384999
    [No Abstract] [Full Text] [Related]

  • 7. Do we still need new oral antibiotics for community-acquired infections in pediatrics? Introduction.
    Adam D.
    Pediatr Infect Dis J; 1995 Apr; 14(4 Suppl):S5-6. PubMed ID: 7792128
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral absorption of cephalosporin antibiotics. 2. Expanded structure-activity relationships of 7-(arylacetamido)-3-substituted cephalosporins.
    Pfeil-Doyle J, Draheim SE, Kukolja S, Ott JL, Counter FT.
    J Med Chem; 1988 Oct; 31(10):1993-7. PubMed ID: 3172135
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative in vitro activity of cefpirome and other antimicrobial agents against isolates from cancer patients.
    Rolston K, Alvarez ME, Hoy JF, LeBlanc B, Ho DH, Bodey GP.
    Chemotherapy; 1986 Oct; 32(4):344-51. PubMed ID: 3731920
    [Abstract] [Full Text] [Related]

  • 13. Cefepime: the next generation?
    Sanders CC.
    Clin Infect Dis; 1993 Sep; 17(3):369-79. PubMed ID: 8218678
    [Abstract] [Full Text] [Related]

  • 14. [Cefoperazone (Medocef*) in the modern therapy of severe bacterial infections].
    Fomina IP, Smirnova LB.
    Antibiot Khimioter; 2001 Sep; 46(10):35-41. PubMed ID: 11881192
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo antibacterial activities of ME1220 and ME1221, novel cephalosporins.
    Okamoto R, Tamura A, Yoshida T, Komiya I, Ogino H, Inouye S, Kondo S, Inoue M, Mitsuhashi S.
    Drugs Exp Clin Res; 1991 Sep; 17(4):205-12. PubMed ID: 1794294
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.